JP2011500575A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500575A5 JP2011500575A5 JP2010528941A JP2010528941A JP2011500575A5 JP 2011500575 A5 JP2011500575 A5 JP 2011500575A5 JP 2010528941 A JP2010528941 A JP 2010528941A JP 2010528941 A JP2010528941 A JP 2010528941A JP 2011500575 A5 JP2011500575 A5 JP 2011500575A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydrogen
- fluoro
- ethyl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001153 fluoro group Chemical group F* 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- -1 cyanomethyl Chemical group 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 208000019695 Migraine disease Diseases 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 2
- 206010027599 migraine Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97946407P | 2007-10-12 | 2007-10-12 | |
| US60/979,464 | 2007-10-12 | ||
| PCT/US2008/078294 WO2009048765A1 (en) | 2007-10-12 | 2008-09-30 | 5-ht7 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011500575A JP2011500575A (ja) | 2011-01-06 |
| JP2011500575A5 true JP2011500575A5 (enExample) | 2011-11-10 |
| JP5291716B2 JP5291716B2 (ja) | 2013-09-18 |
Family
ID=40134870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010528941A Expired - Fee Related JP5291716B2 (ja) | 2007-10-12 | 2008-09-30 | ５−ｈｔ７受容体拮抗薬 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7910588B2 (enExample) |
| EP (1) | EP2201002B1 (enExample) |
| JP (1) | JP5291716B2 (enExample) |
| KR (1) | KR101161070B1 (enExample) |
| CN (1) | CN101821257B (enExample) |
| AT (1) | ATE548365T1 (enExample) |
| AU (1) | AU2008311154B2 (enExample) |
| BR (1) | BRPI0818450A2 (enExample) |
| CA (1) | CA2699674C (enExample) |
| CY (1) | CY1112709T1 (enExample) |
| DK (1) | DK2201002T3 (enExample) |
| EA (1) | EA016787B1 (enExample) |
| ES (1) | ES2380756T3 (enExample) |
| HR (1) | HRP20120257T1 (enExample) |
| MX (1) | MX2010003986A (enExample) |
| PL (1) | PL2201002T3 (enExample) |
| PT (1) | PT2201002E (enExample) |
| SI (1) | SI2201002T1 (enExample) |
| WO (1) | WO2009048765A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI396857B (zh) * | 2009-12-30 | 2013-05-21 | Etron Technology Inc | 晶片測試電路 |
| JP2014528462A (ja) | 2011-10-11 | 2014-10-27 | ユセベ ファルマ ソシエテ アノニム | ２−オキソ−ピペリジニル誘導体 |
| EP2970223B1 (en) | 2013-03-11 | 2020-04-15 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| TW201601632A (zh) * | 2013-11-20 | 2016-01-16 | 杜邦股份有限公司 | １－芳基－３－烷基吡唑殺蟲劑 |
| WO2016040554A1 (en) | 2014-09-10 | 2016-03-17 | Temple University-Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| WO2018093818A1 (en) | 2016-11-15 | 2018-05-24 | Temple University-Of The Commonwealth System Of Higher Education | Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use |
| EP3600289A4 (en) | 2017-03-21 | 2020-08-05 | Temple University - Of The Commonwealth System of Higher Education | 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465467B1 (en) * | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| US20030008880A1 (en) | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| EP1592772A2 (en) * | 2003-01-31 | 2005-11-09 | Pfizer Products Incorporated | 5ht7 antagonists and inverse agonists |
| US7211783B2 (en) | 2004-01-09 | 2007-05-01 | Tamperproof Container Licensing Corp. | Tamper-proof container |
| RU2006146985A (ru) | 2004-05-28 | 2008-07-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецепторов |
| TW200914020A (en) * | 2007-08-28 | 2009-04-01 | Lilly Co Eli | Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists |
-
2008
- 2008-09-30 ES ES08836911T patent/ES2380756T3/es active Active
- 2008-09-30 US US12/678,345 patent/US7910588B2/en not_active Expired - Fee Related
- 2008-09-30 AT AT08836911T patent/ATE548365T1/de active
- 2008-09-30 WO PCT/US2008/078294 patent/WO2009048765A1/en not_active Ceased
- 2008-09-30 DK DK08836911.1T patent/DK2201002T3/da active
- 2008-09-30 EA EA201070462A patent/EA016787B1/ru not_active IP Right Cessation
- 2008-09-30 EP EP08836911A patent/EP2201002B1/en not_active Not-in-force
- 2008-09-30 HR HR20120257T patent/HRP20120257T1/hr unknown
- 2008-09-30 PT PT08836911T patent/PT2201002E/pt unknown
- 2008-09-30 SI SI200830580T patent/SI2201002T1/sl unknown
- 2008-09-30 MX MX2010003986A patent/MX2010003986A/es active IP Right Grant
- 2008-09-30 AU AU2008311154A patent/AU2008311154B2/en not_active Ceased
- 2008-09-30 CN CN2008801107600A patent/CN101821257B/zh not_active Expired - Fee Related
- 2008-09-30 PL PL08836911T patent/PL2201002T3/pl unknown
- 2008-09-30 KR KR1020107007725A patent/KR101161070B1/ko not_active Expired - Fee Related
- 2008-09-30 CA CA2699674A patent/CA2699674C/en not_active Expired - Fee Related
- 2008-09-30 JP JP2010528941A patent/JP5291716B2/ja not_active Expired - Fee Related
- 2008-09-30 BR BRPI0818450 patent/BRPI0818450A2/pt active Search and Examination
-
2012
- 2012-04-26 CY CY20121100400T patent/CY1112709T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011519854A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2011500575A5 (enExample) | ||
| JP2013505969A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| TR201904655T4 (tr) | Piridilaminoasetik asit bileşiği. | |
| JP2014525420A5 (enExample) | ||
| JP2010526814A5 (enExample) | ||
| JP2011529054A5 (enExample) | ||
| JP2010536766A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| JP2012530765A5 (enExample) | ||
| JP2013507423A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2010501478A5 (enExample) | ||
| JP2008513467A5 (enExample) | ||
| JP2013510125A5 (enExample) | ||
| PH12012500752A1 (en) | Benzimidazole-imidazole derivatives | |
| MX2010003156A (es) | Derivados de aril amida substituida con tetrazol y usos de los mismos. | |
| JP2014521625A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| JP2012507535A5 (enExample) | ||
| JP2014504646A5 (enExample) | ||
| NO20092058L (no) | Heteroaryl pyrrolidinyl ketonderivater | |
| JP2013542980A5 (enExample) |